supply of - lacosamide 100mg inj , piracetam 3 gm inj 200 mgperml 15 ml , ceftazidime 2mg with avibactam sodium 0point 5 gm inj , diltiazem 5mgperml inj , n- acetylcystein respules , tobramycin respule 300 mgper5ml , aztreonam 1 gm inj , nimodipine inj 0point 2mg to 0point 6 mgperml vial of 50ml infusio , hypertonic saline 3 percentage bottle of 100 ml for iv use , 3percentage nacl respules , enoxaparin 60mgper0point 6ml inj , naloxone 0point 4mgperml 1ml ampoule inj , doxycycline 100mg inj , me

Indian Army has invited bids for the supply of - lacosamide 100mg inj , piracetam 3 gm inj 200 mgperml 15 ml , ceftazidime 2mg with avibactam sodium 0point 5 gm inj , diltiazem 5mgperml inj , n- acetylcystein respules , tobramycin respule 300 mgper5ml , aztreonam 1 gm inj , nimodipine inj 0point 2mg to 0point 6 mgperml vial of 50ml infusio , hypertonic saline 3 percentage bottle of 100 ml for iv use , 3percentage nacl respules , enoxaparin 60mgper0point 6ml inj , naloxone 0point 4mgperml 1ml ampoule inj , doxycycline 100mg inj , methylene blue 1percentage 10 mgperml amp of 10 ml , thiamine 100 mgperml inj 2ml amp , ceftriaxone 1gm with disodium adetat 37 mgwith salbactum 0po , levonadifloxacin injection ipoint vpoint 800mgper100 ml , inj milrinone amp of 10mgper10ml , n acetylcysteine 100 mg inj , colistimethate 1mu inj , azithromycin 500 mg inj , daptomycin 350 mg inj , protamine sulphate 1percentage 5ml inj , cefepime 1gm and tazobactam 125mg powder for injection , sodium valproate 100mgperml inj , dopamine hcl 40mgperml 5ml inj , polymixin b 5 00 000 units inj renally safe , levetiracetam 100mgperml inj vial of 5ml , streptomycin 1g inj , pralidoxime 500mgper20ml inj , acyclovir 250 mg inj , amino acid 7 percentage wperv 250ml bottle , clindamycin 300mg per2ml inj , inj ropivacaine 5 mgperml 20 ml amp , inj rocuronium 10 mgperml 10 ml vial , isoflurane bottle of 100ml , ketamine hcl 50 mgperml 2 ml inj , propofol 1 per or 10mgperml 20 ml , bupivacaine hcl 5 mgperml 20 ml inj , bupivacaine hcl 5mgperml heavy 4ml inj , inj etomidate 2 mgperml 10 ml vial , atropine sulphate 0point 6 mg 1 ml inj , dexmedetomidine 100mcgperml in 2ml amp inj , diclofenac sodium suppository 100mg , paracetamol 1 gmper100 ml inj bottle , fentanyl citrate 50mcgperml 2ml inj , fentanyl 50mcgperml 10 ml inj , pethedine 50mg 1ml inj , adrenaline tartrate 1 ratio 1000 inj 1 ml , dexamethasone sodium phosphate 4point 4mg equivalent to dex , tranexamic acid 500 mgper5ml inj , adenosine 3 mgperml 2 ml inj , amiodarone hcl 150mg 3ml inj , esmolol 100mg 10ml inj , lignocaine hcl solution 2percentage inj for iv use 50 ml , metoprolol 1mgperml 5ml inj , phenylepherine 10mg 1ml inj , lignocaine 2point 5percentage with prilocaine 2point 5percentag , methylergometrine maleate 0point 2mg 1ml inj , oxytocin 5 units per 1point 0ml amppoint inj , neostigmine 0point 5mg 1ml inj , succinylchloline chloride 50 mgperml 2 ml inj , vecuronium bromide 4mgperml 1ml inj , rocuronium 50 mgper5ml inj , nasal decongestant adulit drops xylometazoline hcl 0point 1percentage wperv nasal drop bott of 10 ml , calcium 9mg with calcium gluconate 50mg inj for iv use 10ml in , intralipid 20percentage 250 ml inj , inj nitroglycerineper glyceryltrinitrate 5 mgperml 10 ml amp - ifa 25 re drugs | quantity - 76552. The estimated project cost is ₹0.35 Cr. Please refer to the tender document for EMD details. Interested bidders can submit applications until 24 September 2026, with the technical opening scheduled for 24 September 2026.